Login

Chelsea Therapeutics International, Ltd. SEC Filings

Filed On Filing
03 Jul 2014 15-12G
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
26 Jun 2014 EFFECT
25 Jun 2014 Form 4: Stoll Roger G Phd, Director

Disposed of 40,000 shares (Tender Offer) · Disposed of 310,000 Stock Option (Right to Buy) (Disposition to Issuer)

25 Jun 2014 Form 4: Hewitt L Arthur, Chief Scientific Officer

Disposed of 58,683 shares (Tender Offer) · Received 218,923 shares by exercise or conversion ($380K) · Returned 218,923 shares to the issuer · 1 more

25 Jun 2014 Form 4: Rueckert William Dodge, Director

Disposed of 50,000 shares (Tender Offer) · Disposed of 280,000 Stock Option (Right to Buy) (Disposition to Issuer)

25 Jun 2014 Form 4: Weiser Michael, Director

Disposed of 450,178 shares (Tender Offer) · Received 27,500 shares by exercise or conversion ($179K) · Returned 27,500 shares to the issuer · 1 more

25 Jun 2014 Form 4: Clemens Kevan, Director

Disposed of 5,000 shares (Tender Offer) · Disposed of 465,210 Stock Option (Right to Buy) (Disposition to Issuer)

25 Jun 2014 Form 4: Schmidt Keith, Chief Commercial Officer

Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) ($194K)

25 Jun 2014 Form 4: Roberts Michael J, VP, Business Development

Disposed of 22,000 shares (Tender Offer) · Received 109,878 shares by exercise or conversion ($99.9K) · Returned 109,878 shares to the issuer · 1 more

25 Jun 2014 Form 4: Oliveto Joseph, Director

Disposed of 3,500 shares (Tender Offer) · Received 490,000 shares by exercise or conversion ($980K) · Returned 490,000 shares to the issuer · 1 more

25 Jun 2014 Form 4: Riehle J Nick, Chief Financial Officer

Disposed of 66,183 shares (Tender Offer) · Received 368,923 shares by exercise or conversion ($1.02M) · Returned 368,923 shares to the issuer · 1 more

25 Jun 2014 Form 4: Schwieterman William D, Chief Medical Officer

Disposed of 130,592 shares (Tender Offer) · Received 350,000 shares by exercise or conversion ($1.04M) · Returned 350,000 shares to the issuer · 1 more

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support